" class="no-js "lang="en-US"> Stephen From - Medtech Alert
Tuesday, April 16, 2024
Stephen From

Stephen From

About Stephen From

>15 years of experience in the pharmaceutical  industry • 10 years as President, CEO, & Chairman, EyeGate Pharmaceuticals, Inc.(NASDAQ: EYEG) • Expertise in corporate finance

Related Story

Aruna Bio Advances Therapeutic Development for Traumatic Brain Injury

June 1 2022

Aruna Bio, Inc., a leader in the development of neural exosome based therapeutics for the […]